Vertex (VERX) announced the expansion of its Chief Strategy Office with the addition of Christopher Hall and Kathya Capote Peimbert. Their extensive experience in e-invoicing, global tax ...

Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing in Parts A and B of the Phase 1/2 VX-264 study and ...

Vertex maintains a leadership position in the CF market, with its treatments widely recognized as the standard of care. The company’s focus on innovation and pipeline expansion has allowed it to ...

Vertex Pharmaceuticals Incorporated VRTX announced updates on its two novel investigational candidates, zimislecel (formerly VX-880) and VX-264, which are being developed in separate studies for ...

Zimislecel (VX-880) pivotal trial on track to complete enrollment and dosing in H1 2025; Vertex expects to submit marketing applications to global regulators in 2026 - Vertex has completed ...

TORONTO (Reuters) - The approximately 600,000-bpd Keystone oil pipeline from Canada to the United States remained shut down Wednesday after an oil spill near Fort Ransom, North Dakota, on Tuesday ...